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Abstract
Background: There are significant differences in the meaning and use of the term ‘Reverse Innovation’ between
industry circles, where the term originated, and health policy circles where the term has gained traction. It is often
conflated with other popularized terms such as Frugal Innovation, Co-development and Trickle-up Innovation.
Compared to its use in the industrial sector, this conceptualization of Reverse Innovation describes a more complex,
fragmented process, and one with no particular institution in charge. It follows that the way in which the term
‘Reverse Innovation’, specifically, is understood and used in the healthcare space is worthy of examination.
Methods: Between September and December 2014, we conducted eleven in-depth face-to-face or telephone
interviews with key informants from innovation, health and social policy circles, experts in international comparative
policy research and leaders in the Reverse Innovation space in the United States. Interviews were open-ended with
guiding probes into the barriers and enablers to Reverse Innovation in the US context, specifically also informants'
experience and understanding of the term Reverse Innovation. Interviews were recorded, transcribed and analyzed
thematically using the process of constant comparison.
Results: We describe three main themes derived from the interviews. First, ‘Reverse Innovation,’ the term, has
marketing currency to convince policy-makers that may be wary of learning from or adopting innovations from
unexpected sources, in this case Low-Income Countries. Second, the term can have the opposite effect - by
connoting frugality, or innovation arising from necessity as opposed to good leadership, the proposed innovation
may be associated with poor quality, undermining potential translation into other contexts. Finally, the term
‘Reverse Innovation’ is a paradox – it breaks down preconceptions of the directionality of knowledge and learning,
whilst simultaneously reinforcing it.
Conclusions: We conclude that this term means different things to different people and should be used
strategically, and with some caution, depending on the audience.
Keywords: Diffusion of innovation, Evidence based medicine, Developing countries
Background
Building on Christiansen’s notion of the ‘disruptive
innovation’ [1], in the management literature the term
‘Reverse Innovation’ was first coined by Immelt [2]
and then popularized by Govindarajan and Trimble
[3]. Concerned that incumbent corporations would
lose market share due to an inability to innovate, ‘Re-
verse Innovation’ was then the idea that disruptive in-
novations are best developed by first scaling them in
low-income countries - lower barriers to entry, lower
costs, and broader market base (bottom of the pyra-
mid) – and then pursue market penetration back in
the high-income country context [4]. The example of
GE’s ultrasound machine and portable ECG machine
are most-often cited: they were developed through
local subsidiary organizations in India at a fraction of
the cost and then introduced into the US market. In
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the management literature, the ‘Reverse Innovation’
process takes place within the boundaries, albeit often
complex and diffuse ones, of the same multinational
corporation [4]. Govindarajan and Trimble’s notion of
Reverse Innovation is thus strategic and supply-led –
developing a low-cost product to disrupt incumbents
and develop new markets for growth.
In healthcare circles, however, ‘Reverse Innovation’ is
taken to mean learning from, or diffusion of, the innova-
tions that low-income countries have themselves developed
and perhaps even scaled. This is a very different and far
more complex process than that described in the manage-
ment literature. Following Rogers [5], DePasse and Lee [6]
suggest that it requires a ‘cross-over’ from Low-Income
country early adopters to High-Income country innovators.
They argue that Reverse Innovation requires ‘spannable so-
cial distances’ bridged by policymakers, entrepreneurs and
health system leaders and utilizing diverse channels such as
conferences, learning collaboratives and online resources
[6]. From the high-income country (adopter) perspective it
requires, first, knowledge of the innovation, then belief that
it confers an advantage, and then persuasion of diverse local
health system actors to consider it and adopt it. Compared
to its use in the industrial sector, this conceptualization of
Reverse Innovation describes a far more complex and frag-
mented process: one with no particular institution in
charge, and blurring the lines between supply and demand.
The actors driving this process may include innovation
think tanks, health policy organizations and foundations
and their work is to create demand – demand for the
innovation and demand for local service providers inter-
ested (or persuaded) to pilot or adopt the innovation [7].
Reverse Innovation has become somewhat of a ‘move-
ment’ – there is now a widespread array of organizations
involved in this area, but also the increasing knowledge
base that uses the term generated through academic, peer-
reviewed publications as well as popular management lit-
erature. Following Brown and Zavestoski (2004) we define
healthcare social movements as collective challenges to
medical policy, public health policy and politics, belief sys-
tems, research and practice. Reverse Innovation fits this
definition because of its challenge to the conceptualization
that learning goes one way [8]. In healthcare circles, the
claim to ‘newness’ of the ‘Reverse Innovation’ movement is
curious. The notion that low-income countries have a lot
to offer is not at all new. In the 1990s, Morgan and Rau [9]
curated dozens of low-income country innovations worthy
of adoption in high-income contexts in a process then
known as ‘Global Learning for Health’. In 2004, the BMJ
dedicated an entire volume to the learning that high-
income countries could achieve from low-income ones,
without one mention of the term ‘Reverse Innovation.’ In
2010, Lord Nigel Crisp, former Chief Executive of the NHS
and Permanent Secretary of the UK Department of Health
wrote that “It is increasingly recognized that innovation
needs to be sourced globally’ but refers to this as a process
of ‘co-development’ [10]. Clearly, one thing that is new
about the ‘Reverse Innovation’ movement in health is its
name [11].
Finally, there is an array of existing terms and often
inter-changeable meanings that conjure different connota-
tions or imagery to the contemporary umbrella term of
‘Reverse Innovation’. These include Frugal Innovation or
Frugal Engineering [12], Innovation Blowback [13], Social
Innovation [14], Co-development [10], as well as Trickle-
up innovation, Bottom of Pyramid, Social entrepreneur-
ship, and Leap-frogging. Although these terms and their
meanings are related to innovative approaches, in and be-
yond healthcare, they nevertheless span geographic and
thematic boundaries, having developed independently of
the term ‘Reverse Innovation’. Other colloquial terms such
as ‘jugaad’ (India), ‘hack’ (U.S.), and ‘Système D’ (France)
also refer to innovative fixes or simple work-arounds that
solve complex issues. Additional file 1 provides more detail
on some of these terms.
It follows that the way in which the term ‘Reverse
Innovation’, specifically, is understood and used in the
healthcare space is worthy of examination. This question
constitutes one aspect of a broader deep dive into the
barriers and challenges of the ‘Reverse Innovation’
process in the US that we undertook between September
2014 and June 2015. Here we present findings from in-
terviews conducted with key informants and experts,
each with experience of, or an interest in, Reverse
Innovation or broader cross-country learning and diffu-
sion of innovation. As part of interviews that explored in
general the barriers and enablers to Reverse Innovation
in the US, we asked our informants what they thought
of the term ‘Reverse Innovation’, specifically focusing on
their understanding, experience of and use of the term
‘Reverse Innovation’, and the connotations that it evokes,
if any.
Methods
Sampling
Informants were selected purposefully from institutions
and organizations known to have an interest in the Reverse
Innovation space, and attention was given to ensure that
there was representation from academic, non-profit foun-
dation, health system management and innovation think
tanks. To ensure an even wider representation, informants
were also identified from both executive and managerial
cadres and from those with experience or interest in inter-
national policy exchange in diverse disciplinary areas such
as healthcare, as well as educational policy and social policy
reform. Eleven participants were initially identified and all
agreed to participate in the interviews which were con-
ducted in-person or by telephone.
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Data collection
As exploratory research, with a focus on views and experi-
ences, we used an open-ended interview style, loosely
guided by some specific areas of interest, allowing for free-
flowing conversation and examination of divergent themes
[15]. These were to explore experiences of ‘Reverse
Innovation’ in the US context, to identify the barriers and
challenges from the informant’s point of view, and to en-
quire into their understanding of the ‘Reverse Innovation’
construct. Informants were first contacted by email and
once the research was explained and agreement to partici-
pate obtained, interviews were arranged for dates, times
and locations of their convenience. All the interviews were
audio-recorded and verbatim transcripts were obtained
from a commercial transcription company under strict con-
fidentiality. Written informed consent was obtained from
all informants. Participants had the right to withdraw their
consent at any stage without giving a reason although none
exercised this right. To facilitate voluntariness, potential
participants received no inducement to participate. No
identifying information was included in the transcripts and
the informant list is kept securely apart from any data in a
locked filing cabinet. Transcripts were checked and we
removed any identifiable information or references immedi-
ately upon receipt by the research team and stored them in
password-protected files. All interviews lasted between
thirty minutes to an hour.
The research protocol was reviewed by the University
Committee on Activities Involving Human Subject and
deemed exempt from full ethical review (IRB# 14–10294).
Interviews were all conducted by the same researcher
(MH), during the period Sept-Nov 2014, and stopped once
thematic saturation was reached.
Analytical strategy
Two researchers (MH and EW) reviewed all the tran-
scripts and using the first four transcripts independently
indexed thematic categories using the process of constant
comparison [16–19], indexing both vertically, within the
same transcript, and horizontally, across the transcripts.
These early code structures were then reviewed and re-
vised for four further iterations, enabling the codes to be
redefined, merged and retired until a final code structure
had been obtained which was used to then code the
remaining transcripts. Both researchers reviewed all coded
transcripts, all of which had been coded independently
using the final agreed code structure and any coding
disagreements were resolved through consensus. The in-
terviews generated over two hundred pages of verbatim
transcript, which was manually coded. Coded data was or-
ganized into themes and sub-themes and the researchers
identified patterns within the categorized data at higher
levels of abstraction, developing explanatory concepts to
link the themes where possible.
Results
Sales pitch – using the term Reverse Innovation to
persuade
Several informants recognized that the process that Re-
verse Innovation refers to has been called many things
but that this term, most of all, has a distinct, enduring
quality. The claim to ‘newness’ in the Reverse innovation
space obscures a different reality – learning from low-
income countries is not new, but has been called by dif-
ferent names over the years:
‘[pilot project on a significant social policy reform
adopted from Mexico] was a combination of me and
[names a colleague] at the World Bank, thinking
about the challenges associated with north/south
exchange of ideas and this kind of stuff. We didn’t call
it….Reverse Innovation…..What did we call it? Yes…
knowledge sharing.’ Professor of Applied Psychology
(28th October 2014)
The resurgence of interest in this area is inextricably
linked to the name itself, and can in some senses be
viewed as a successfully branded management strategy
to effect organizational change and reignite interest in
learning from low-income countries. Many informants
considered the term Reverse Innovation to be part of a
good ‘sales pitch’ because it uses positive, change lan-
guage managers can understand. It is a popularized
term, suggesting a well-established management strategy
or evoking the sense that there is a body of evidence to
sustain it, giving comfort to policy makers concerned
with adopting a policy from a non-traditional, or non-
familiar, context.
‘I think it [the term Reverse Innovation] is a terrific
sales pitch. When I go to an insurance regulator, it is
much harder to say look, we have some problems here,
they have this great thing in Mexico, let’s try to think
about how that business model can work here. That is
a much harder sales pitch than when I say hey, there’s
this phenomenon called Reverse Innovation, and lots
of people are talking about it, and its this widespread
phenomenon…and this is a particular example of
Reverse Innovation…I think it gives a lot of comfort to
policy makers who are worried about doing something
risky.’ Professor of Law (1st October 2014)
‘The other thing is I think a total preoccupation with
innovation, you know, as a concept. I mean there’s just
such a growth, a proliferation of….its probably the
most overused terms in healthcare today….and if not
in other sectors. It might be just generally in any
business, innovation might be sort of an overused term
overall, you know? And so the notion of innovation
itself has risen to the surface and has…is…has kind of
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become in vogue and kind of the thing.’ VP Innovation
think tank (10th October 2014)
Reverse Innovation is associated with frugality and can
be offensive
Although the term ‘Reverse Innovation’ seems to have
a positive branding quality, the use of and interpret-
ation of the term is not, as many noted, entirely with-
out issue. Many informants recognized that by virtue
of the Reverse Innovation process being associated
with low-income contexts, it could create an immedi-
ate association that the innovation is cheaper than
existing technologies. Whilst many of the innovations
proposed within the Reverse Innovation space are in-
deed cheaper, and although reducing cost on its own
can be an important goal in a health system, many
informants noted that reduced cost can equate to
reduced quality and this makes it harder to be con-
vincing. It renders the term ‘Reverse Innovation’
somewhat counterproductive, damaging the perceived
relative advantage of the innovation, evoking images
of cheap solutions best kept in locations that need to
use them.
Low-income countries such as Ethiopia and Pakistan
have scaled a lay health worker cadre to national levels
with well-described benefits for those contexts. One in-
formant noted that the term ‘Reverse Innovation’, when
associated with adoption of a similar model in the US,
results in a somewhat negative reaction that serves to
undermine the learning aspiration:
‘Well, the term that I’ve often thought about is right-
skilling, which is kind of deskilling, right, which is we
want to have less expensive, less highly trained people
doing certain tasks. That also sounds dangerous…They
say wait a second, all this really is, you know, is going
away from a shiny building into somebody’s garage,
and that’s kind of dangerous when you think about the
healthcare world where these policy makers job is to
keep people safe.’ Professor of Law (1st October 2014)
It is not the innovation per se that evokes a sense of
‘going away from a shiny building into somebody’s garage’
but awareness of the source of the innovation, implied
immediately by the term ‘Reverse Innovation’. The term
‘Reverse Innovation’ invokes the image of low-income
contexts from whence the innovation came. Whether ac-
curate or not, a host of important inferences are subse-
quently made about the context and the innovation. For
example, informants often noted that innovations
worthy of examination from low-income contexts had
been developed ‘out of necessity’ – as if to say, resource-
poor contexts have to do more with less and therefore
the systems that are developed are leaner:
‘I think where it’s gotten traction is the idea that we
really can learn from what’s happening in middle-
and low-income countries because those are the places
where the resource constraints are most severe, and
where the needs are most urgent….we’re learning from
places that have to be frugal by necessity and now we
can learn from that’. Executive Director, Innovation
think tank (1st October 2014)
This narrative is problematic because it asserts that cost
pressures alone, and not good leadership for example, led
somewhat organically to the low-cost/high-value innovation
in the low-income country. It also implies that in the US
there is no cost pressure at all, a burden shouldered only in
low-income contexts. Many informants noted that the use
of the term Reverse Innovation could therefore be consid-
ered as offensive, misplaced or derogatory in the innovator
context:
‘It’s offensive, it’s derogatory for the people that are
coming up with the ideas and it creates already
stereotypes and prejudices so I think it’s a terrible
name….the politicians and leaders of these countries
probably are not that excited about having their
country branded as, you know, an unusual suspect for
a good idea’ Manager, Innovation think tank (1st
October 2014)
Reverse Innovation is a paradox
Our final observation from the interviews is that the term
‘Reverse Innovation’ is somewhat of a paradox. None of the
informants specifically referred to the term ‘Reverse
Innovation’ as being a paradox however reviewing the inter-
pretations and uses of the term leads us to consider it being
one. First of all, the term Reverse Innovation has stuck:
‘I’ve seen other terms. I’ve seen bidirectional or
multidirectional innovation, or generalized innovation,
which somehow gets there….but none of these have the
same kind of cultural cachet….or the same kind of
penetration or regularity of use as Reverse Innovation.
Reverse Innovation, for whatever reason, seems to have
stuck, as you know, as the phrase that people recognize
this kind of innovation by.’ VP Innovation think tank
(10th October 2014)
even though many do not like the term at all:
‘Well I don’t like the term Reverse Innovation….I hate
it.’ (Senior Manager, Innovation think tank (1st
October 2014)
‘….none of us like the term at all. It’s something we’ve
talked a lot about, both as a team but with, of course,
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our cooperators in this space, and [fact that the term
is very problematic] comes up in our meetings.’
Manager, Innovation think tank (1st October 2014)
The term readily perpetuates the same colonial world-
view that it supposedly serves to break down:
‘…the term assumes you’re taking ideas from countries
either in transition or with nothing and taking what
they’re doing in a frugal or low resource way and
making it useful here because if they had the same
means that we had you wouldn’t necessarily need to
brand it that way…..you would just call it knowledge
sharing or like stimulating idea flow or something, it
would be totally flat….’ Senior Manager, Innovation
think tank (1st October 2014)
‘….it [the term Reverse Innovation] assumes a world
in which the flow of information is expected to go from
high income to low income countries, and anything
happening in the other direction would be reverse….I
find that problematic.’ Manager, Innovation think
tank (1st October 2014)
‘…like we were at the center of innovation all the time,
most of it we export and give to you [low-income
countries] and now we’re going to reverse it, it trickles
back.’ Senior Manager, Innovation think tank (1st
October 2014)
‘….I try and get away from this notion that there’s an
us-and-them kind of concept, which I think is embed-
ded in the notion of “Reverse Innovation” ‘VP
Innovation think tank (10th October 2014)
This ‘colonial view’ is so deeply entrenched within the
term ‘Reverse Innovation’, that one informant admitted
to feelings of exploitation when drawing on the experi-
ences of a low-income country. In the following excerpt,
the informant describes a fairly convoluted, institutional
approach to mitigate ‘exploiting’ the low-income coun-
try. There is a distinct sense that using knowledge, ex-
perience or evidence from a low-income context is not
fair game, something needs to be given back:
‘…..arguably, we could do the learning from these
projects without ever making any grant, you know,
without providing funding to these organizations. We
could go and visit them and talk to them, sort of,
extract that learning and then think about how to
come back here and get it going in the United States,
but, I think, we wanted to be conscious of not
appearing like we were exploiting that, those
organizations particularly in the Global South. So our
grant funding is a bit transactional in some ways.
That is, that, sort of, our support of their work allows
us, I think, to feel like it’s a bit of an exchange, in a
way that makes us feel like we’re not taking advantage
of them but, sort of, respectfully treating them like the
peers that they are.’Assistant Vice President, Research
Foundation (14th November 2014)
Informants noted that the complexity of adopting in-
novations from the UK or other contexts ‘similar’ to the
US is just as much as if they were from a low-income
context. Health systems, regulatory barriers, scope-of-
practice law, finance and professional boundaries make
the transfer of innovation or learning as complex be-
tween rich countries as between poor countries. Some
argued that, in some senses, there are more similarities
between the UK and Ghana as there are between the UK
and the US:
‘…you could go further with this. You could make the
argument that structurally, the Ghanian system is far
closer to the UK system than the American system will
ever be….it is centrally administered, district-based
health system, much like the NHS is. And so theoretic-
ally, ideas from Ghana would be more relevant than
ideas from the US. But that’s not how the learning
works. And that’s the cultural arrogance piece of the
postcolonial legacy that I think interferes.’ Vice
President Innovation think tank (10th October 2014)
If diffusion of innovation is as complex between high-
income contexts as it is from low-to-high contexts, then
it is as much of a curiosity that learning has tended to
happen between the ‘usual suspects’ – high-income
countries with geo-political or regional ties. The learning
process, or diffusion of innovation from low-to-high in-
come countries, whilst in theory probably no different in
complexity to diffusion of innovations between high-
income contexts, clearly possesses additional layers of
complexity due to the challenges resulting in overcom-
ing recipient sentiment regarding the source of the
innovation. As one respondent puts it – "that’s not how
the learning works". There are deeply embedded, preva-
lent and enduring assumptions that the global North
teaches, and the global South, learns. The conflicting
sentiments that the informants noted in using the term
‘Reverse Innovation’ is due to the term synthetically
meaning two conflicting things simultaneously – the
world is flat, but really it isn’t.
Discussion
In recent years, the North–south model of development,
rooted in post-colonial assistance, has been heralded as
archaic [11]. Development has been called into question
as an industry that is often self-serving [20–22] and fail-
ing to demonstrate significant change [23, 24]. Also, the
global health landscape has changed dramatically. Power
and influence is more diffuse with a proliferation of
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significant new actors [25, 26], and emerging economies
continue to challenge established markets. There are
many examples of impressive health innovations origin-
ating from low- or middle-income countries [10, 27–44].
These have the potential to disrupt health systems; in-
deed there are many reasons why the bloated healthcare
economies of high-income countries could benefit from
leaner innovations and out-of-the-box thinking.
Keeping pace with these changes, the ‘Reverse
Innovation’ movement recognizes that knowledge,
skills and learning can come from anywhere, and even
flow from low to high-income countries. It is no sur-
prise that ‘Reverse Innovation’ has come to be a buzz-
word heard in many innovation, management and
healthcare circles. In 2012, a thematic series in
Globalization and Health set out to explore and pro-
mote ‘Reverse Innovation’. In 2013, the Ivey Inter-
national Centre for Health Innovation issued an open
call to invite proposals for ‘Reverse Innovations’ that
could address Canada’s health system challenges [45].
More recently, the International Partnership for Innovative
Healthcare Delivery (IPIHD), recently renamed Innova-
tions in Healthcare (IIH) formed out of a partnership be-
tween the World Economic Forum, Duke University, and
McKinsey & Company, operates a ‘Reverse Innovation’
working group to address how successful innovations in
healthcare delivery from low-income settings can be repli-
cated in high-income settings. The Centre for Health Mar-
ket Innovations (http://healthmarketinnovations.org) and
the Institute for Global Health Innovation collate many
examples of potentially adoptable innovations (http://
www.imperial.ac.uk/centre-for-health-policy/our-work/
innovation-research-/).
Don Berwick, former Administrator of the Centers for
Medicare and Medicaid Services wrote about the inspir-
ing ideas that Low-income countries held, saying “We
may well find ourselves not the teachers we thought we
were, but students of those who simply will not be
stopped under circumstances that would have stopped
us long ago” [31]. Although there is increasingly vocal
recognition of the potential to learn from low-income
countries, the most recent incarnation, as a process of
‘Reverse Innovation,’ as opposed to other more neutral
terminology is steeped in persistent attitudes that learn-
ing ought really still go the other way.
It is curious that the ‘Reverse Innovation’ term has
gained traction in healthcare circles even when its use
connotes a very different process to that in the manage-
ment literature, where it originated. Its use in the man-
agement literature is less loaded, because it describes a
process that occurs within the same organizational
boundaries of a Multinational Corporation, managing a
strategic entry into new markets, and where ownership
of the Intellectual Property of the product is clear. When
the term ‘Reverse Innovation’ is used in the healthcare
space, the actors involved are entirely different, often dif-
fuse, often without direct delivery capacity, and often the
‘owner’ of the innovation may have no interest per se in
exporting it. Furthermore, often the innovation may be a
technology but it may also be a process, a service, a type
of new cadre, or even simply a principle, with no specific
intellectual property ownership from the perspective of
the innovator context. The motivation for and the driver
of the learning process are both also one-sided – all
from the high-income context. Low-income country in-
novators are not explicitly selling or exporting their
ideas to high-income countries.
Our study shows that although it may be a strategic
lever to persuade actors in an organizational change
process in high-income countries, the risk highlighted
by respondents here in the US is that the ‘Reverse
Innovation’ narrative may send negative signals to po-
tential adopters and also to the innovator contexts. As-
sociation of Reverse Innovation with frugality risks
potential adopters viewing the innovation as a poor al-
ternative to existing practice. The availability and pro-
duction of cheap products is not limited to low-income
countries, and this type of thinking raises important
questions about how people in the US determine the
value of goods, and speaks more to the US psyche than
those producing innovations themselves. Equally, lean
innovations may have been developed in low-income
countries from good leadership not from the necessity of
poverty. The suggestion that these countries would not
have been able to develop innovative solutions had the
cost pressure not been present may be offensive. It is
not known whether low-income country actors would
themselves agree with this sentiment – the perspectives
of actors in these settings where the Reverse Innovations
are developed have been largely absent from the discus-
sion [46]. Future research might draw on the social mar-
keting literature to better understand how these terms
evoke positive and negative connotations.
From the perspective of a high-income country, learning
from a context that might be considered to be ‘on par’ with
the US would be termed something somewhat less loaded
such as diffusion of innovation, or bidirectional innovation.
However, learning from a low-income context is has been
given the term Reverse Innovation perhaps because it runs
counter to the prevailing notion of where knowledge, ex-
perience or evidence is considered to generally derive from.
This sentiment evokes the same sense of paradox, or even
oxymoron, as the phrase ‘patient-centered care’ might [47]
or ‘affirmative action’. If care were truly patient-centered it
would be inappropriate to refer to individuals as patients -
it is a term very much centered on the healthcare profes-
sional. ‘Affirmative action’ (the process) aims to redress an
important inequity but ‘affirmative action’ (the term)
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simultaneously reinforces it. Reverse Innovation, similarly,
is oxymoronic – as if to say ‘we like your idea but feel
threatened that you came up with it – we’re going to pre-
tend that we view you as peers.’ ‘Reverse Innovation’ clearly
evokes different things to different people and in our re-
search, the term has complex, multi-layered, sometimes
positive, sometimes negative, connotations. Future research
should study the impacts and repercussions of the term
‘Reverse Innovation’ within the innovator contexts. But
also more research is needed to explore the views of and
impact of Reverse Innovation (the term and the process) in
the source, low-income country contexts, in particular to
examine further the presence (or absence) of any sense of
exploitation as noted in our findings. The study of Reverse
Innovation, although of benefit to populations in high-
income countries, requires also the voice of those in low-
and middle-income countries. There is a need for a better
understanding of the supply side for innovations, and how
to develop the market of ideas from these contexts. Link-
ing in with our notion of ‘cultural arrogance’, there is a
need to understand whether actors in low- and middle-
income countries are enabled to promote their solutions
and innovations to the countries that have historically been
the providers, not the beneficiaries, of assistance.
Until this research is available, it is probably sensible
to use the term sparingly, that is, think carefully about
whom it is used for and by, as it will evoke different
things to different people.
Greenhalgh [48] has already called for terms such as
‘knowledge translation’ to be dropped because they con-
strain how the link between knowledge and practice is
conceptualized. They propose that discourse analysis
might be used to make explicit the process by which cer-
tain types and sources of knowledge become defined as
‘best evidence’ and that a much wider menu of meta-
phors to illustrate the non-linear, networked generation,
circulation and sharing of ‘knowledge’ is needed. Terms
such as knowledge sharing, diffusion of innovation, dis-
ruptive innovation and social innovation are agnostic
with respect to the development and income status of
the countries involved in the sharing process but also do
little to accurately represent the translation, implementa-
tion and scaling of innovation. It is simplistic to describe
it as either a linear (translation) or passive (diffusion)
process. If the adoption, for want of a better word, of in-
novations from low- to high-income countries is indeed
a different process to that between high-income coun-
tries, then a definitive taxonomy is needed to establish
how best to describe it, when and to whom.
Conclusion
We cannot step into the minds of our informants [49]
but through this type of inquiry we can infer certain is-
sues based on the narratives and experiences of our
informants. The term ‘Reverse Innovation’ seems to at-
tend to enduring sensibilities that knowledge that mat-
ters is ostensibly produced by high-income countries.
However, at the same time, the use of the term may also
have value as part of the sales pitch part of the process
when it is perceived to be going the ‘other way’. The
‘cultural arrogance’ referred to by our informants speaks
to a resistant, hegemonic perspective akin to hubris –
excessive pride. Although it is the high-income country
actors that are seeking out ideas for reform from con-
texts that traditionally were considered the weaker, fra-
gile and resource-poor contexts, ‘Reverse Innovation’
mitigates the bruising of collective pride that such a
process might inflict. To contrast, why not just call it
‘learning’, for example?
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